Page 5 - Anjali Singh

Weak IP regime clouds pharma growth despite GST cuts, says BMI report

BMI warned India's weak IP protections deter global drugmakers, limiting access to innovative therapies, even as GST cuts on 33 lifesaving drugs lower costs and boost affordability

New drug offers hope for Indians with drug-resistant hypertension

Baxdrostat lowered systolic blood pressure in trials and could benefit Indian patients with resistant hypertension by reducing side effects of older drugs

Hospitals may raise IT innovation spend by 20-25% amid AI boost: Report

CII-EY survey finds AI, automation, and data-led tools driving hospital tech investments despite challenges in integration and workforce readiness

Sun Pharma's Halol plant gets OAI classification from US FDA inspection

US FDA has classified Sun Pharma's Halol facility in Gujarat as OAI, keeping it under import alert, signalling possible enforcement action unless corrective steps are taken

Glenmark gains 3% on $700 mn upfront payment from AbbVie licensing deal

Glenmark shares rose 3% after confirming receipt of $700 million from AbbVie under a global licensing deal for ISB 2001, with milestone payments of up to $1.2 billion

TVS invests ₹100 cr in NTorq 150 launch, eyes festive scooter demand

TVS Motor has invested Rs 100 crore in its NTorq 150 Hyper Sport Scooter, aiming to capture festive-season demand and consolidate its position in the premium scooter market

Anti-obesity diabetes drugs receive WHO's essential medicine tag

India is preparing for large-scale generic launches

Citroen to double India market share in 3 months with Basalt X SUV

Citroen eyes stronger India play with Basalt X SUV, aiming to double market share in three months while exports from Thiruvallur are projected to cross 10,000 units in FY26

Pharma market grows 8.7% in August; cardiac and anti-diabetic segments lead

The Indian Pharma Market grew 8.7% in August 2025, with the cardiac, anti-diabetic, and anti-neoplastic segments driving growth. Sun Pharma maintained its leadership position

Patients to benefit from GST rate cut, but firms likely to face pressure

GST rationalisation lowers costs for medical consumables and high-end therapies, benefiting patients. However, pharma companies, particularly in biologics, may face margin pressure due to ITC loss

New GST rates revive auto companies' hope for a festive sales spurt

Small petrol and diesel cars now attract only 18 per cent GST compared to 29-31 per cent earlier

From cancer drugs to glucometers, patients to save more after GST cuts

GST Council removed tax on 33 life-saving drugs and slashed GST on all medicines and medical devices to 5%, easing treatment costs and improving healthcare access

GST cut makes cars, bikes, tyres cheaper, Diwali comes for Auto Inc

GST Council cut rates on small cars, bikes, SUVs and tyres, slashing levies to 18% and rationalising slabs, a move hailed as transformative for the auto industry

Poly Medicure to acquire Netherlands-based PendraCare for ₹188.5 crore

Poly Medicure has signed agreements to acquire 90 per cent of Netherlands-based PendraCare Group for Rs 188.5 crore, expanding its cardiology business in Europe and the US

Royal Enfield, TVS, and Hero rise on festival buzz; Bajaj, Honda slip

Two-wheeler sales in August 2025 rose for Royal Enfield, TVS, Hero and Suzuki, while Bajaj and Honda reported declines, with festive demand and GST reforms set to boost outlook

Medanta opens 550-bed super specialty hospital in Noida, Delhi-NCR

Medanta has launched a 550-bed super specialty hospital in Noida with advanced technologies, expanding its NCR presence and addressing healthcare needs in Western Uttar Pradesh

Fortis signs 15-year sub-lease to run Greater Noida hospital facility

Fortis Healthcare has signed a 15-year sub-lease with R.R. Lifesciences to operate a hospital in Greater Noida, expanding its NCR presence with a monthly rent of Rs 2.4 crore

Butterfly Learnings launches CDSCO-approved autism screening tool in India

Butterfly Learnings has rolled out 'Get Set Early', India's first CDSCO-approved autism screening tool using eye-tracking and behavioural analysis for children aged 1-4 years

Analysts see auto demand rebound in H2 FY26 on GST relief and rate cuts

Brokerages see repo and CRR rate cuts, along with a likely GST rate reduction as key triggers

AHPI revokes advisory to stop cashless services for Bajaj Allianz clients

There is an urgent need for a health regulator to ensure transparency and fairness across the healthcare ecosystem, GI Council Chairman